Exact Mass: 631.253
Exact Mass Matches: 631.253
Found 74 metabolites which its exact mass value is equals to given mass value 631.253
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mesaconitine
Mesaconitine is a diterpenoid. Mesaconitine is a natural product found in Aconitum anthora, Aconitum napellus, and other organisms with data available. Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid Annotation level-1 Mesaconitine is the main active component of genus aconitum plants. IC50 value: Target: in vitro: In HUVECs, 30 microM mesaconitine increased the [Ca(2+)](i) level in the presence of extracellular CaCl(2) and NaCl, and the response was inhibited by KBR7943. Mesaconitine increased intracellular Na(+) concentration level in HUVECs. The [Ca(2+)](i) response by mesaconitine was inhibited by 100 microM D-tubocurarine [1]. Mesaconitine at 30 microM inhibited 3 microM phenylephrine-induced contraction in the endothelium-intact, but not endothelium-denuded, aortic rings [2]. MA promoted the alpha-MT-induced decrease in NE levels in hippocampus, medulla oblongata plus pons and spinal cord [3]. Mesaconitine is the main active component of genus aconitum plants. IC50 value: Target: in vitro: In HUVECs, 30 microM mesaconitine increased the [Ca(2+)](i) level in the presence of extracellular CaCl(2) and NaCl, and the response was inhibited by KBR7943. Mesaconitine increased intracellular Na(+) concentration level in HUVECs. The [Ca(2+)](i) response by mesaconitine was inhibited by 100 microM D-tubocurarine [1]. Mesaconitine at 30 microM inhibited 3 microM phenylephrine-induced contraction in the endothelium-intact, but not endothelium-denuded, aortic rings [2]. MA promoted the alpha-MT-induced decrease in NE levels in hippocampus, medulla oblongata plus pons and spinal cord [3].
Efonidipine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000077264 - Calcium-Regulating Hormones and Agents D045283 - Natriuretic Agents > D004232 - Diuretics D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Elagolix
Gliadins
Isolated from wheat flour or wheat gluten
Mesaconitine
tricaffeoyl spermidine
Tricaffeoyl spermidine belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. Tricaffeoyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Tricaffeoyl spermidine can be found in a number of food items such as black radish, breadfruit, persimmon, and jicama, which makes tricaffeoyl spermidine a potential biomarker for the consumption of these food products.
Elagolix Sodium
1beta,7beta,11-triacetoxy-4alpha-hydroxy-5alpha-nicotinoyl-8-alpha-tiglyloxydihydroagarofuran|triptersinine L
Met Arg Tyr Tyr
Met Tyr Arg Tyr
Met Tyr Tyr Arg
Arg Met Tyr Tyr
Arg Tyr Met Tyr
Arg Tyr Tyr Met
Thr Trp Tyr Tyr
Thr Tyr Trp Tyr
Thr Tyr Tyr Trp
Trp Thr Tyr Tyr
Trp Tyr Thr Tyr
Trp Tyr Tyr Thr
Tyr Met Arg Tyr
Tyr Met Tyr Arg
Tyr Arg Met Tyr
Tyr Arg Tyr Met
Tyr Thr Trp Tyr
Tyr Thr Tyr Trp
Tyr Trp Thr Tyr
Tyr Trp Tyr Thr
Tyr Tyr Met Arg
Tyr Tyr Arg Met
Tyr Tyr Thr Trp
Tyr Tyr Trp Thr
Gliadin
5(6)-CARBOXY-X-RHODAMINE-N-HYDROXYSUCCINIMIDE ESTER
6-Carboxy-X-rhodamine succinimidyl ester,6-ROX, SE
elagolix
H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01C - Hypothalamic hormones > H01CC - Anti-gonadotropin-releasing hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Mgb-BP-3
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins
3-(7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis-phenoxymethyl-1L6-[1,2,7]thiadiazepan-2-ylmethyl)-N-methyl-benzamide
Efonidipine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000077264 - Calcium-Regulating Hormones and Agents D045283 - Natriuretic Agents > D004232 - Diuretics D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
6-[(3S,6S,9S,12R)-3-benzyl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]hexanoic acid
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(1r,2s,3s,5r,7s,10s,11s,12s,15r,16s,17r,19s)-8-ethyl-15,17-dihydroxy-3,12,16-trimethoxy-10-(methoxymethoxy)-6-oxa-8-azahexacyclo[15.2.1.0²,⁷.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]icos-13-en-18-yl 4-methoxybenzoate
(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16s,17s,18r)-8-(acetyloxy)-11-ethyl-5,7,14,16-tetrahydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
(2e)-3-(3,4-dihydroxyphenyl)-n-{3-[(2e)-3-(3,4-dihydroxyphenyl)-n-(4-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}butyl)prop-2-enamido]propyl}prop-2-enimidic acid
8-(acetyloxy)-11-ethyl-5,7,14,16-tetrahydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1α,6α,14α,15α,16β)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac,n-formyl
{"Ingredient_id": "HBIN010680","Ingredient_name": "4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1\u03b1,6\u03b1,14\u03b1,15\u03b1,16\u03b2)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac,n-formyl","Alias": "NA","Ingredient_formula": "C32H41NO12","Ingredient_Smile": "NA","Ingredient_weight": "631.67","OB_score": "NA","CAS_id": "125286-17-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7779","PubChem_id": "NA","DrugBank_id": "NA"}